Downloads: 2 | Views: 104 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Medicine | India | Volume 10 Issue 7, July 2021
Prevalence of Co-Morbidity Diseases in Suspected Corona Virus Disease-19 Patients
Dr. Shashi Bhushan B. L. | Dr. Nagaraja C. L. | Dr. Arun B. J. | Dr. Deepa A. S. | Dr. Nivedha .S
Abstract: Introduction: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a lifethreatening respiratory disease in those patients having underlying medical condition and has worse prognosis irrespective of the age of patient. Subjects and Methods: A prospective study conducted at dedicated COVID-19 hospital, Bengaluru. Detailed history of underlying medical conditions, Clinical examination and nasopharyngeal and oropharyngeal swab collection were done for all the patients visiting Victoria. Hospital with a history of suspicion of COVID-19. The collected swab was tested for SARS-CoV-2as per ICMR approved protocol. (7) Results: Among 13634 patients attending the fever clinic of pulmonary medicine department in Victoria hospital attached to Bangalore Medical College Research Institute 839 patients were excluded as they did not fit the inclusion criteria. Half of (6637) the patients were asymptomatic at the time of presentation. Twenty five percent (3199) of the suspected COVID-19 and fifty percent (765) of confirmed COVID-19 patients had at least one comorbid condition. The most common underlying medical condition of both confirmed and suspected COVID-19 patients was Hypertension (32.06%>17.64%) followed by diabetic mellitus (22.4%>14.81%), cardio-vascular diseases (10.81%<11%), chronic pulmonary diseases (2.31%<4.43%), cerebrovascular diseases (0.77%<2.93%), chronic renal diseases (0.32%<1.76%), chronic liver diseases (0.32%<2.23%), and malignancy (0.12%<0.87%). Conclusion: Fifty percent of confirmed COVID-19 patients had at least one underlying medical condition. Hypertension and diabetes mellitus had higher prevalence in confirmed COVID-19 patients in that order. 50% of COVID positive patients were asymptomatic at the time of presentation.
Keywords: SARS-CoV-2, COVID-19, Co-Morbidity diseases
Edition: Volume 10 Issue 7, July 2021,
Pages: 1133 - 1136